Article Details
Retrieved on: 2021-08-10 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life- ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here